Ameriprise’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $349M | Sell |
5,573,439
-857,645
| -13% | -$68.6M | 0.08% | 256 |
|
|
2025
Q4 | $613M | Buy |
6,431,084
+939,522
| +17% | +$92.1M | 0.14% | 152 |
|
|
2025
Q3 | $536M | Sell |
5,491,562
-2,295,397
| -29% | -$238M | 0.12% | 175 |
|
|
2025
Q2 | $838M | Sell |
7,786,959
-64,744
| -0.8% | -$6.55M | 0.21% | 105 |
|
|
2025
Q1 | $792M | Sell |
7,851,703
-254,065
| -3% | -$25.6M | 0.21% | 97 |
|
|
2024
Q4 | $724M | Sell |
8,105,768
-100,157
| -1% | -$8.82M | 0.19% | 112 |
|
|
2024
Q3 | $688M | Buy |
8,205,925
+306,315
| +4% | +$24.1M | 0.18% | 125 |
|
|
2024
Q2 | $608M | Buy |
7,899,610
+1,824,405
| +30% | +$134M | 0.16% | 135 |
|
|
2024
Q1 | $416M | Sell |
6,075,205
-1,449,424
| -19% | -$93.2M | 0.11% | 194 |
|
|
2023
Q4 | $435M | Buy |
7,524,629
+2,165,709
| +40% | +$116M | 0.13% | 173 |
|
|
2023
Q3 | $283M | Sell |
5,358,920
-2,565,258
| -32% | -$135M | 0.09% | 223 |
|
|
2023
Q2 | $429M | Sell |
7,924,178
-1,741,971
| -18% | -$91M | 0.13% | 166 |
|
|
2023
Q1 | $484M | Sell |
9,666,149
-82,520
| -0.8% | -$3.89M | 0.16% | 145 |
|
|
2022
Q4 | $451M | Sell |
9,748,669
-272,316
| -3% | -$11.8M | 0.15% | 147 |
|
|
2022
Q3 | $388M | Buy |
10,020,985
+1,054,619
| +12% | +$42.3M | 0.14% | 158 |
|
|
2022
Q2 | $334M | Buy |
8,966,366
+7,454,042
| +493% | +$303M | 0.12% | 194 |
|
|
2022
Q1 | $66.6M | Sell |
1,512,324
-506,366
| -25% | -$21.9M | 0.02% | 678 |
|
|
2021
Q4 | $85.6M | Buy |
2,018,690
+189,647
| +10% | +$7.97M | 0.02% | 625 |
|
|
2021
Q3 | $79.4M | Sell |
1,829,043
-252,776
| -12% | -$11.2M | 0.03% | 586 |
|
|
2021
Q2 | $89M | Buy |
2,081,819
+270,550
| +15% | +$11.4M | 0.03% | 568 |
|
|
2021
Q1 | $70M | Buy |
1,811,269
+8,572
| +0.5% | +$324K | 0.02% | 626 |
|
|
2020
Q4 | $64.8M | Sell |
1,802,697
-3,114,695
| -63% | -$112M | 0.02% | 628 |
|
|
2020
Q3 | $188M | Buy |
4,917,392
+397,577
| +9% | +$15.3M | 0.08% | 263 |
|
|
2020
Q2 | $159M | Buy |
4,519,815
+1,965,964
| +77% | +$70.8M | 0.07% | 284 |
|
|
2020
Q1 | $83.3M | Buy |
2,553,851
+179,884
| +8% | +$7.03M | 0.04% | 382 |
|
|
2019
Q4 | $107M | Sell |
2,373,967
-27,587
| -1% | -$1.15M | 0.04% | 398 |
|
|
2019
Q3 | $97.6M | Buy |
2,401,554
+251,879
| +12% | +$10.7M | 0.04% | 412 |
|
|
2019
Q2 | $92.4M | Sell |
2,149,675
-28,909
| -1% | -$1.11M | 0.04% | 445 |
|
|
2019
Q1 | $83.6M | Buy |
2,178,584
+128,585
| +6% | +$4.91M | 0.04% | 472 |
|
|
2018
Q4 | $72.4M | Buy |
2,049,999
+279,585
| +16% | +$10.1M | 0.04% | 482 |
|
|
2018
Q3 | $68.4M | Buy |
1,770,414
+88,801
| +5% | +$3.1M | 0.02% | 590 |
|
|
2018
Q2 | $55M | Sell |
1,681,613
-340,214
| -17% | -$10.3M | 0.02% | 632 |
|
|
2018
Q1 | $55.2M | Buy |
2,021,827
+63,689
| +3% | +$1.73M | 0.03% | 602 |
|
|
2017
Q4 | $48.5M | Sell |
1,958,138
-142,557
| -7% | -$3.93M | 0.02% | 598 |
|
|
2017
Q3 | $61.3M | Buy |
2,100,695
+193,710
| +10% | +$5.35M | 0.03% | 500 |
|
|
2017
Q2 | $52.9M | Buy |
1,906,985
+387,611
| +26% | +$10.3M | 0.03% | 536 |
|
|
2017
Q1 | $37.8M | Sell |
1,519,374
-152,628
| -9% | -$3.71M | 0.02% | 657 |
|
|
2016
Q4 | $36.2M | Buy |
1,672,002
+595,032
| +55% | +$13M | 0.02% | 657 |
|
|
2016
Q3 | $25.6M | Sell |
1,076,970
-1,482,466
| -58% | -$35.4M | 0.01% | 789 |
|
|
2016
Q2 | $59.8M | Sell |
2,559,436
-1,557,544
| -38% | -$33.7M | 0.04% | 429 |
|
|
2016
Q1 | $77.4M | Sell |
4,116,980
-212,336
| -5% | -$3.73M | 0.05% | 371 |
|
|
2015
Q4 | $79.8M | Buy |
4,329,316
+364,201
| +9% | +$6.53M | 0.05% | 352 |
|
|
2015
Q3 | $65.1M | Buy |
3,965,115
+2,315,265
| +140% | +$39.6M | 0.04% | 392 |
|
|
2015
Q2 | $29.2M | Sell |
1,649,850
-1,344,718
| -45% | -$24M | 0.02% | 766 |
|
|
2015
Q1 | $53.1M | Buy |
2,994,568
+2,392,639
| +397% | +$37.8M | 0.03% | 508 |
|
|
2014
Q4 | $7.97M | Buy |
601,929
+24,152
| +4% | +$309K | ﹤0.01% | 1700 |
|
|
2014
Q3 | $6.82M | Sell |
577,777
-575,510
| -50% | -$7.25M | ﹤0.01% | 1796 |
|
|
2014
Q2 | $14.7M | Sell |
1,153,287
-63,088
| -5% | -$820K | 0.01% | 1245 |
|
|
2014
Q1 | $16.4M | Sell |
1,216,375
-4,985,932
| -80% | -$65.4M | 0.01% | 1142 |
|
|
2013
Q4 | $74.6M | Sell |
6,202,307
-3,932,261
| -39% | -$46.5M | 0.05% | 389 |
|
|
2013
Q3 | $119M | Sell |
10,134,568
-886,902
| -8% | -$9.59M | 0.08% | 273 |
|
|
2013
Q2 | $102M | Buy |
+11,021,470
| New | +$93.5M | 0.07% | 314 |
|
Other funds holding BSX
VCM
VPM
Ameriprise's BSX Position: Q1 2026 in Review
Ameriprise reduced its Boston Scientific (BSX) stake by 13% in Q1 2026, selling an estimated $68.6M and leaving 5,573,439 shares worth $349M. The position accounts for 0.08% of the portfolio, ranked #256.
Ameriprise first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $838M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Ameriprise held 5,573,439 shares of Boston Scientific worth $349M as of Q1 2026.
- Ameriprise sold 857,645 Boston Scientific shares in Q1 2026, an estimated $68.6M.
- Boston Scientific made up 0.08% of Ameriprise's portfolio in Q1 2026, its #256 holding.
- Ameriprise first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Boston Scientific position peaked at $838M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.